A 72-year-old woman goes home from a mid-size community hospital after a successful knee replacement. Her vitals are stable, her incision is healing, her discharge paperwork is textbook. Three weeks later she’s back in the emergency department, not because of her knee, but because her zip code is a food desert with no easy way to reach a pharmacy or a grocery store. Nothing in her chart captured that risk, because nothing ever asked about it.
That gap isn’t rare, and it points to something structural: hospitals are still measuring readmission risk with tools built to explain the past, not to see what’s coming.
For more than a decade, hospitals have leaned on retrospective analytics to calculate the readmission measures the Centers for Medicare & Medicaid Services (CMS) uses to set penalties. Open-source platforms like the Tuva Project have become a genuine standard here, turning claims data into comparable quality benchmarks for more than 100 providers and health plans. That standardization is useful. It is also, by design, backward-looking: it tells administrators what already happened, not what is about to. As CMS tightens performance windows, hospitals need a different orientation, from reporting readmissions to preventing them.
The money involved keeps climbing. In fiscal year 2026, 240 hospitals, 8.1% of those evaluated, face Medicare readmission penalties of 1% or more of their reimbursement. That’s up from 208 hospitals the year before, according to a September 2025 Becker’s Hospital Review analysis. Not all of that is a quality signal, though. A January 2026 study in JAMA Network Open found that unobserved differences in which patients a hospital treats account for $284 to $297 million in penalty redistribution across hospitals annually. That’s a sign some of what gets penalized is patient mix, not care.
A different architecture
Fixing this needs more than a better dashboard. I’ve been building what I call the Predictive Continuum Model, an artificial intelligence (AI)-driven framework organized around four pillars that current readmission tools don’t touch:
- Social determinants of health (SDOH). Natural language processing on clinical notes, combined with outside geospatial data, surfaces housing instability, transportation gaps, and similar risks that never make it into structured electronic health record (EHR) fields.
- Dynamic fall risk. Continuous models read real-time signals, medication changes, gait-tracking data from a phone or smartwatch, across the full 30 days after discharge, replacing the one-time, admission-day Morse Fall Scale.
- Intelligent post-care tracking. Flagging patients most likely to miss follow-up appointments or stop taking medication, so care coordinators spend limited home-visit and telehealth capacity where it prevents the most returns.
- Organizational alignment. A resource-allocation layer weighs predicted readmission surges against elective-surgery schedules and staffing, so the beds and case managers readmission-prone patients need aren’t competing with planned procedures.
What the evidence actually shows
None of this belongs on a whiteboard alone. The published record is narrower than some vendor pitches suggest, but it’s real. An AI-driven care pathway cut 30-day readmissions by 48% among high-risk chronic obstructive pulmonary disease (COPD) patients specifically, according to a 2022 Scientific Reports study by Wang and colleagues. That figure is not for high-risk patients as a general category. A separate multi-hospital deployment aimed at sepsis-related stays reported a 22.7% reduction, per a 2020 evaluation in BMJ Health & Care Informatics. Single-site deployments in general-medicine populations reported smaller, still real gains, 25% and roughly 14%, respectively, in two Applied Clinical Informatics studies (Romero-Brufau et al., 2020; Wu et al., 2021).
How much non-clinical, social factors like housing and transportation drive health outcomes is genuinely contested. The widely cited World Health Organization (WHO) Commission on Social Determinants of Health estimate runs roughly 30-55%. Some U.S.-specific cohort studies, by contrast, put the figure at 80-90%. Both come from real research; they aren’t interchangeable, and no single study spans the whole range. CMS’s own recent posture on SDOH data has moved the other way, too: its FY2026 inpatient and outpatient payment rules both dropped SDOH-screening measures from quality reporting, citing provider burden.
Augmenting, not replacing
None of this replaces the nurse, case manager, or social worker who makes the actual call. It’s meant to point them at the right patient sooner, surfacing a smaller number of higher-precision cases instead of adding to alert fatigue, one of the real barriers to clinical AI adoption.
The bottom line
Value-based penalties aren’t shrinking, and retrospective reporting alone won’t reduce them. The harder question for hospital leadership is how much they’re willing to invest in the SDOH data quality and systems-integration work that separates a promising model from one that survives contact with daily practice.
About Karthikeya Rekulapalli
Karthikeya Rekulapalli is a data architect specializing in EDI/FHIR interoperability and healthcare data pipelines at Midland Memorial Health.
